Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, December 1999, p. 2841-2847, Vol. 43, No. 12
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Interaction between Fluconazole and Amphotericin B
in Mice with Systemic Infection Due to Fluconazole-Susceptible or
-Resistant Strains of Candida albicans
Arnold
Louie,1,2,*
Partha
Banerjee,1,2
George L.
Drusano,1,3
Mehdi
Shayegani,2 and
Michael H.
Miller1,3
Division of Infectious
Diseases1 and Clinical
Pharmacology,3 Department of Medicine, Albany
Medical College, Albany, New York 12208, and Wadsworth Center,
New York State Department of Health, Albany, New York
122012
Received 10 July 1998/Returned for modification 13 December
1998/Accepted 8 September 1999
The interaction between fluconazole (Flu) and amphotericin B (AmB)
was evaluated in a murine model of systemic candidiasis for one
Flu-susceptible strain (MIC, 0.5 µg/ml), two strains with intermediate Flu resistance (Flu mid-resistant strains) (MIC, 64 and
128 µg/ml), and one highly Flu-resistant strain (MIC, 512 µg/ml) of
Candida albicans. Differences in fungal densities in kidneys of infected mice after 24 h of therapy and in survival rates at 62 days of mice treated with an antifungal drug or a combination of antifungal drugs for 4 days were compared. For the
Flu-susceptible and Flu mid-resistant strains, the combination of Flu
and AmB was antagonistic, as shown by both quantitative culture results
and survival. The interaction was additive for the highly Flu-resistant
strain. These results suggest that the combination of Flu and AmB
should be used with caution in infections due to fungi that are usually
susceptible to both antifungal agents and as empirical antifungal drug therapy.
*
Corresponding author. Mailing address: Division of
Infectious Diseases, Mail Code-49, Albany Medical College, 47 New
Scotland Ave., Albany, NY 12208. Phone: (518) 262-6548. Fax: (518)
262-6727. E-mail:
arnold_louie_at_amc01-3{at}ccgateway.amc.edu.
Antimicrobial Agents and Chemotherapy, December 1999, p. 2841-2847, Vol. 43, No. 12
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Cacciapuoti, A., Gurnani, M., Halpern, J., Norris, C., Patel, R., Loebenberg, D.
(2005). Interaction between Posaconazole and Amphotericin B in Concomitant Treatment against Candida albicans In Vivo. Antimicrob. Agents Chemother.
49: 638-642
[Abstract]
[Full Text]
-
Mukherjee, P. K., Sheehan, D. J., Hitchcock, C. A., Ghannoum, M. A.
(2005). Combination Treatment of Invasive Fungal Infections. Clin. Microbiol. Rev.
18: 163-194
[Abstract]
[Full Text]
-
MacCallum, D. M., Odds, F. C.
(2004). Need for Early Antifungal Treatment Confirmed in Experimental Disseminated Candida albicans Infection. Antimicrob. Agents Chemother.
48: 4911-4914
[Abstract]
[Full Text]
-
Cuenca-Estrella, M.
(2004). Combinations of antifungal agents in therapy-what value are they?. J Antimicrob Chemother
54: 854-869
[Abstract]
[Full Text]
-
Barchiesi, F., Spreghini, E., Maracci, M., Fothergill, A. W., Baldassarri, I., Rinaldi, M. G., Scalise, G.
(2004). In Vitro Activities of Voriconazole in Combination with Three Other Antifungal Agents against Candida glabrata. Antimicrob. Agents Chemother.
48: 3317-3322
[Abstract]
[Full Text]
-
Johnson, M. D., MacDougall, C., Ostrosky-Zeichner, L., Perfect, J. R., Rex, J. H.
(2004). Combination Antifungal Therapy. Antimicrob. Agents Chemother.
48: 693-715
[Full Text]
-
Matthews, R. C., Rigg, G., Hodgetts, S., Carter, T., Chapman, C., Gregory, C., Illidge, C., Burnie, J.
(2003). Preclinical Assessment of the Efficacy of Mycograb, a Human Recombinant Antibody against Fungal HSP90. Antimicrob. Agents Chemother.
47: 2208-2216
[Abstract]
[Full Text]
-
Andes, D.
(2003). In Vivo Pharmacodynamics of Antifungal Drugs in Treatment of Candidiasis. Antimicrob. Agents Chemother.
47: 1179-1186
[Full Text]
-
Petraitis, V., Petraitiene, R., Groll, A. H., Sein, T., Schaufele, R. L., Lyman, C. A., Francesconi, A., Bacher, J., Piscitelli, S. C., Walsh, T. J.
(2001). Dosage-Dependent Antifungal Efficacy of V-Echinocandin (LY303366) against Experimental Fluconazole-Resistant Oropharyngeal and Esophageal Candidiasis. Antimicrob. Agents Chemother.
45: 471-479
[Abstract]
[Full Text]
-
Louie, A., Kaw, P., Banerjee, P., Liu, W., Chen, G., Miller, M. H.
(2001). Impact of the Order of Initiation of Fluconazole and Amphotericin B in Sequential or Combination Therapy on Killing of Candida albicans In Vitro and in a Rabbit Model of Endocarditis and Pyelonephritis. Antimicrob. Agents Chemother.
45: 485-494
[Abstract]
[Full Text]
-
Louie, A., Liu, W., Miller, D. A., Sucke, A. C., Liu, Q.-F., Drusano, G. L., Mayers, M., Miller, M. H.
(1999). Efficacies of High-Dose Fluconazole plus Amphotericin B and High-Dose Fluconazole plus 5-Fluorocytosine versus Amphotericin B, Fluconazole, and 5-Fluorocytosine Monotherapies in Treatment of Experimental Endocarditis, Endophthalmitis, and Pyelonephritis Due to Candida albicans. Antimicrob. Agents Chemother.
43: 2831-2840
[Abstract]
[Full Text]